London CO Of Virginia Johnson & Johnson Transaction History

London CO Of Virginia

$18.6 Billion
Q3 2024

A detailed history of London CO Of Virginia transactions in Johnson & Johnson stock. As of the latest transaction made, London CO Of Virginia holds 2,098,509 shares of JNJ stock, worth $306 Million. This represents 1.82% of its overall portfolio holdings.

Number of Shares

2,098,509

Previous 2,216,085 5.31%

Holding current value

$306 Million

Previous $324 Million 5.0%

% of portfolio

1.82%

Previous 1.83%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $17.1 Million - $19.7 Million	-117,576 Reduced 5.31%	2,098,509 $340 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $17.3 Million - $18.9 Million	-119,555 Reduced 5.12%	2,216,085 $324 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $10.5 Million - $11 Million	-67,642 Reduced 2.81%	2,335,640 $369 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $24.8 Million - $27.1 Million	-170,673 Reduced 6.63%	2,403,282 $377 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $10.9 Million - $12.2 Million	-69,820 Reduced 2.64%	2,573,955 $401 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $9.04 Million - $9.73 Million	-58,569 Reduced 2.17%	2,643,775 $438 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $11.3 Million - $13.5 Million	-74,740 Reduced 2.69%	2,702,344 $419 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $772,324 - $866,767	4,821 Added 0.17%	2,777,084 $491 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $11.4 Million - $12.7 Million	70,776 Added 2.62%	2,772,263 $453 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $14.3 Million - $15.8 Million	-84,905 Reduced 3.05%	2,701,487 $480 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $10.2 Million - $11.5 Million	64,278 Added 2.36%	2,786,392 $494 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $11.8 Million - $13.1 Million	-75,904 Reduced 2.71%	2,722,114 $466 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $8.82 Million - $9.8 Million	54,598 Added 1.99%	2,798,018 $452 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $4.6 Million - $4.93 Million	28,820 Added 1.06%	2,743,420 $452 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $11.1 Million - $12.4 Million	72,696 Added 2.75%	2,714,600 $446 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $44.2 Million - $50.8 Million	322,720 Added 13.92%	2,641,904 $416 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $98 Million - $107 Million	698,409 Added 43.09%	2,319,184 $345 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $2.98 Million - $3.59 Million	23,106 Added 1.45%	1,620,775 $228 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $405,772 - $562,217	3,651 Added 0.23%	1,597,669 $210 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1.92 Million - $2.21 Million	-15,060 Reduced 0.94%	1,594,018 $233 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $1.49 Million - $1.67 Million	-11,770 Reduced 0.73%	1,609,078 $208 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $677,258 - $744,855	5,164 Added 0.32%	1,620,848 $226 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $2.81 Million - $3.12 Million	22,352 Added 1.4%	1,615,684 $226 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $19.2 Million - $23.1 Million	-156,025 Reduced 8.92%	1,593,332 $206 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $212 Million - $249 Million	1,744,867 Added 38861.18%	1,749,357 $242 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $116,968 - $138,510	-935 Reduced 17.24%	4,490 $575,000
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $14,302 - $15,654	-109 Reduced 1.97%	5,425 $763,000
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $716,486 - $749,192	5,534	5,534 $719,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of London CO Of Virginia, based on Form 13F filings with the SEC.

News

Stay updated on London CO Of Virginia with notifications on news.

Account

London CO Of Virginia Johnson & Johnson Transaction History